Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Senescence induction dictates response to chemo- and immunotherapy in preclinical models of ovarian cancer

Proceedings of the National Academy of Sciences(2022)10.1073/pnas.2117754119Source: DataRank Database

Senescence induction dictates response to chemo- and immunotherapy in preclinical models of ovarian cancer is a research paper published in Proceedings of the National Academy of Sciences (2022). On theSindex it has a DataRank of 0.673. It has been cited 88 times.

N/A

0.673DataRank · unranked

Scored on demand from live citation data

Open Access88 citations

Download PDF

Cite:

Linked data & code

geo doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (16 grants)OA: hybridTopics (32)IDs (PubMed, PMC)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.673

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (14)

Camilla Salvagno ORCID,Yu-Jui Ho ORCID,Matthew Limjoco,Timour Baslan ORCID,Sha Tian ORCID

Live enrichment

PubMed:35082152 PMC:PMC8812522

HHS | NIH | National Cancer Institute

Grant: P30 CA008748 55

HHS | National Institutes of Health

Grant: R01CA233944 02

HHS | National Institutes of Health

Grant: R01NS114653; R21CA248106

U.S. Department of Defense

Grant: OC150111

U.S. Department of Defense

Grant: W81XWH2110357; OC200166; OC109443

EIF | Stand Up To Cancer

Grant: SU2C-AACR-IRG-03-16; SU2C-AACR-PS24

Deutsche Forschungsgemeinschaft

Grant: EXC 2180 - 390900677

NCI NIH HHS

Grant: P30 CA008748

NCI NIH HHS

Grant: R01 CA233944

NINDS NIH HHS

Grant: R01 NS114653

NCI NIH HHS

Grant: R21 CA248106

National Institutes of Health

Grant: 5R01NS114653-02

Endoplasmic Reticulum Stress Responses in Pain

Deutsche Forschungsgemeinschaft

Grant: unidentified

unidentified

National Institutes of Health

Grant: 1R21CA248106-01

IRE1a-XBP1 Signaling as a Driver of Chemotherapy-Induced Peripheral Neuropathy

National Institutes of Health

Grant: 2P30CA008748-43

MOUSE GENETICS

National Institutes of Health

Grant: 5R01CA233944-04

Rapid and flexible precision oncology mouse models of epithelial malignancies epithelial malignancies

hybridLicense: CC BY

publisherhttp://www.pnas.org/syndication/doi/10.1073/pnas.2117754119

publisherhttps://pnas.org/doi/pdf/10.1073/pnas.2117754119

Europe_PMChttps://europepmc.org/articles/PMC8812522

Europe_PMChttps://europepmc.org/articles/PMC8812522?pdf=render

https://doi.org/10.1073/pnas.2117754119

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

Cell Line, TumorAnimalsMice, Inbred C57BLHumansMiceOvarian NeoplasmsDisease Models, AnimalAntineoplastic AgentsImmunotherapyFemaleCarcinoma, Ovarian EpithelialImmune Checkpoint Inhibitors

Keywords

SenescenceOvarian cancerCancer ImmunotherapyMouse ModelsOvarian NeoplasmsAntineoplastic AgentsBiological SciencesCarcinoma, Ovarian EpithelialMice, Inbred C57BLDisease Models, AnimalMiceCell Line, TumorAnimalsHumansFemaleImmunotherapyImmune Checkpoint Inhibitors

Sustainable Development Goals

SDG 3: 3. Good health